274 related articles for article (PubMed ID: 20870723)
1. Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils.
Ren R; Hong Z; Gong H; Laporte K; Skinner M; Seldin DC; Costello CE; Connors LH; Trinkaus-Randall V
J Biol Chem; 2010 Nov; 285(48):37672-82. PubMed ID: 20870723
[TBL] [Abstract][Full Text] [Related]
2. Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.
Blancas-Mejía LM; Hammernik J; Marin-Argany M; Ramirez-Alvarado M
J Biol Chem; 2015 Feb; 290(8):4953-4965. PubMed ID: 25538238
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains.
Connors LH; Jiang Y; Budnik M; Théberge R; Prokaeva T; Bodi KL; Seldin DC; Costello CE; Skinner M
Biochemistry; 2007 Dec; 46(49):14259-71. PubMed ID: 18004879
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycans enhance the fibrillation propensity of the β2-microglobulin cleavage variant--ΔK58-β2m.
Corlin DB; Johnsen CK; Nissen MH; Heegaard NH
Biochem Biophys Res Commun; 2010 Nov; 402(2):247-51. PubMed ID: 20939999
[TBL] [Abstract][Full Text] [Related]
5. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
[TBL] [Abstract][Full Text] [Related]
6. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation.
Castillo GM; Lukito W; Wight TN; Snow AD
J Neurochem; 1999 Apr; 72(4):1681-7. PubMed ID: 10098877
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A.
Takase H; Tanaka M; Yamamoto A; Watanabe S; Takahashi S; Nadanaka S; Kitagawa H; Yamada T; Mukai T
Amyloid; 2016 Jun; 23(2):67-75. PubMed ID: 27097047
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid A and monoclonal light-chain amyloid fibrils.
Nelson SR; Lyon M; Gallagher JT; Johnson EA; Pepys MB
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):67-73. PubMed ID: 1902087
[TBL] [Abstract][Full Text] [Related]
9. Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.
Martin EB; Williams A; Wooliver C; Heidel RE; Adams S; Dunlap J; Ramirez-Alvarado M; Blancas-Mejia LM; Lands RH; Kennel SJ; Wall JS
PLoS One; 2017; 12(3):e0174152. PubMed ID: 28350808
[TBL] [Abstract][Full Text] [Related]
10. Heparin binds 8 kDa gelsolin cross-β-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension.
Solomon JP; Bourgault S; Powers ET; Kelly JW
Biochemistry; 2011 Apr; 50(13):2486-98. PubMed ID: 21348501
[TBL] [Abstract][Full Text] [Related]
11. The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity.
Iannuzzi C; Irace G; Sirangelo I
Molecules; 2015 Feb; 20(2):2510-28. PubMed ID: 25648594
[TBL] [Abstract][Full Text] [Related]
12. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro.
Cohlberg JA; Li J; Uversky VN; Fink AL
Biochemistry; 2002 Feb; 41(5):1502-11. PubMed ID: 11814343
[TBL] [Abstract][Full Text] [Related]
13. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
Lim A; Wally J; Walsh MT; Skinner M; Costello CE
Anal Biochem; 2001 Aug; 295(1):45-56. PubMed ID: 11476544
[TBL] [Abstract][Full Text] [Related]
14. Primary localized cutaneous nodular amyloidosis: case report and biochemical analysis of amyloid.
Konohana A; Teraki Y; Tajima S; Araki Y; Kitamura K; Nishikawa T
Dermatologica; 1991; 183(2):114-9. PubMed ID: 1743371
[TBL] [Abstract][Full Text] [Related]
15. Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts.
Martin EB; Williams A; Heidel E; Macy S; Kennel SJ; Wall JS
Biochem Biophys Res Commun; 2013 Jun; 436(1):85-9. PubMed ID: 23707811
[TBL] [Abstract][Full Text] [Related]
16. Molecular interactions in the formation and deposition of beta2-microglobulin-related amyloid fibrils.
Naiki H; Yamamoto S; Hasegawa K; Yamaguchi I; Goto Y; Gejyo F
Amyloid; 2005 Mar; 12(1):15-25. PubMed ID: 16076607
[TBL] [Abstract][Full Text] [Related]
17. Four structural risk factors identify most fibril-forming kappa light chains.
Stevens FJ
Amyloid; 2000 Sep; 7(3):200-11. PubMed ID: 11019861
[TBL] [Abstract][Full Text] [Related]
18. Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro.
Vilasi S; Sarcina R; Maritato R; De Simone A; Irace G; Sirangelo I
PLoS One; 2011; 6(7):e22076. PubMed ID: 21779376
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro.
Yamaguchi I; Suda H; Tsuzuike N; Seto K; Seki M; Yamaguchi Y; Hasegawa K; Takahashi N; Yamamoto S; Gejyo F; Naiki H
Kidney Int; 2003 Sep; 64(3):1080-8. PubMed ID: 12911560
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis.
Ward JE; Ren R; Toraldo G; Soohoo P; Guan J; O'Hara C; Jasuja R; Trinkaus-Randall V; Liao R; Connors LH; Seldin DC
Blood; 2011 Dec; 118(25):6610-7. PubMed ID: 21998211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
